Showing results (301-310 of 335) with videos related to

Sort By:
Pageof 34
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2008
Death receptor 5 mediated-apoptosis contributes to cholestatic liver diseaseKazuyoshi Takeda, Yuko Kojima, Kenichi Ikejima, et al.
Epilepsia|January 6, 2011
HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patientsNahoko Kaniwa, Yoshiro Saito, Michiko Aihara, et al.
American Journal of Human Genetics|February 4, 2018
Biallelic Variants in CNPY3, Encoding an Endoplasmic Reticulum Chaperone, Cause Early-Onset Epileptic EncephalopathyHiroki Mutoh, Mitsuhiro Kato, Tenpei Akita, et al.
Hepatology (Baltimore, Md.)|November 24, 2012
Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinomaTaro Yamashita, Masao Honda, Yasunari Nakamoto, et al.
Internal Medicine (Tokyo, Japan)|September 13, 2021
Repeated Necrotizing Lymphadenitis with MEFV Gene MutationsYuta Yamamura, Kengo Furuichi, Tadashi Toyama, et al.
Acta Oto-Laryngologica|January 25, 2019
Detection of sentinel lymph node using contrast-enhanced agent, Sonazoid™, and evaluation of its metastasis with superb microvascular imaging in oral and oropharyngeal cancers: a preliminary clinical studyNaohiro Wakisaka, Kazuhira Endo, Tomohiro Kitazawa, et al.
Epilepsia|July 21, 2011
CDKL5 alterations lead to early epileptic encephalopathy in both gendersJao-Shwann Liang, Keiko Shimojima, Rumiko Takayama, et al.
Frontiers in Oncology|April 16, 2025
Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitorKoushiro Ohtsubo, Shigeki Sato, Hiroyuki Sakaguchi, et al.
Molecular and Clinical Oncology|January 8, 2021
A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus nab-paclitaxel for resectable pancreatic cancerHidehiro Tajima, Isamu Makino, Ryosuke Gabata, et al.
Radiology|February 11, 2015
Hepatocellular Carcinoma with β-Catenin Mutation: Imaging and Pathologic CharacteristicsAzusa Kitao, Osamu Matsui, Norihide Yoneda, et al.
Pageof 34